Ross M. Campbell, M.D.

Dr. Ross Campbell is board-certified by the American Board of Dermatology and has completed fellowship training in Mohs Surgery and Procedural Dermatology. He recently served on the board of the American Society of Dermatologic Surgery.

A magna cum laude graduate of the University of Georgia and the Medical College of Georgia, Dr. Campbell obtained a two-year fellowship grant from the N.I.H to investigate melanoma immunotherapy at Emory University. With an ultimate goal of opening a skin cancer and aesthetic surgery specialty center, Dr. Campbell chose to complete a general and plastic surgery internship in Seattle, before performing his dermatology residency at Brown Medical School where he served as Chief Resident. Although Mohs surgery can be performed by physicians without completing a fellowship, the pursuit of excellence in medical and surgical care led Dr. Campbell to spend an extra year of fellowship at one of the busiest and most acclaimed Mohs surgery and cosmetic dermatology practices in the country, under the directorship of Gary Monheit, M.D, and Chris Harmon, M.D. During his fellowship, which was a combined ACGME procedural dermatology fellowship, Dr. Campbell performed nearly 3,000 Mohs surgery cases and became an expert in aesthetic procedures such as blepharoplasty, hair transplantation, chemical peels, soft tissue fillers, dermabrasion, and Botox Cosmetic.

Dr. Campbell has lectured nationally, instructing dermatologists and plastic surgeons on various aspects of dermatologic and aesthetic surgery. He has published in numerous dermatologic and cosmetic surgery journals and authored several book chapters on surgical and cosmetic procedures.

Dr. Campbell and his family -- wife Leigh and son Aidan -- moved to Athens in 2007 to open Georgia Skin Cancer and Aesthetic Dermatology and to be closer to other family members. Ross and Leigh both attended the University of Georgia and have a strong attachment to the region. Leigh is a medical illustrator and an accomplished equestrian event rider.

Curriculum Vitae
Ross Martin Campbell, M.D., F.A.A.D.

Peer Reviewed Publications:

1. Lang R, Landen J, McMahon S, Adams A, Campbell R, Bonaccorsi, Archer D, Ansel J, H Joshi, and C Armstrong.  The Alkaloid noscapine is a low toxicity agent with significant antitumor effects in melanoma.  J Invest Dermatol 2001;117:568.
2. Landen JW, Lang R, McMahon SJ, Rusan NM, Yvon AM, Adams AW, Sorcinelli MD, Campbell R, Bonaccorsi P, Ansel JC, Archer DR, Wadsworth P, Armstrong CA, Joshi HC. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res 2002;62:4109-14.
3. Ramos-Ceballos F, Campbell RM, Kowalczyk A, CA Armstrong and JC Ansel.  The cutaneous neuropeptide substance P is chemotactic for human dermal microvascular endothelial cells. J Invest Dermatol 2002;119:210.
4. Campbell RM, Pham A, Compans R, JC Ansel and CA Armstrong.  Newcastle Disease Virus oncolysate induces a significant and specific anti-melanoma effect in a preclinical murine model system. J Invest Dermatol 2002;119:216.
5. Campbell RM, Perlis CS, Fisher E, Gloster, Jr. HM. Gentamycin ointment versus petrolatum for management of auricular wounds. Dermatol Surg 2005;31:664-9.
6. Campbell RM, Barrall D, Wilkel C, Robinson-Bostom L, Dufresne, Jr., RG. Post-Mohs margin tissue evaluation with permanent histopathologic sections. Dermatol Surg 2005;31:655-8.
7. Campbell RM, Mader RD, Dufresne Jr. RG. Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndrome. J Amer Acad Derm 2005;53:S256-9.
8. Perlis CS, Campbell RM, Malik M, Dufresne Jr RG. Incidence of and risk factors for medical malpractice lawsuits among Mohs surgeons. Dermatol Surg. 2006;32:79-83.
9. Campbell RM, Barrall D, Wilkel C, Robinson-Bostom L, Dufresne, Jr., RG. Recurrence of nonmelanoma skin cancer after post-Mohs margin tissue evaluation with permanent histopathological sections. Dermatol Surg 2006;32:463.
10. Campbell RM, Regan, L, Muglia, J, Dufresne RG, Robinson-Bostom L. Bednar Tumor.  Cosmetic Dermatology 2006;19:422-424.
11. Campbell RM, DiGiovanna JJ. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients. Dermatologic Therapy 2006;19:306-314.
12. Ahmed S, Campbell RM, Li JH, Robinson-Bostom L, Wang LJ. Adenoma of anogenital mammary-like glands. J Amer Acad Derm. In Press.
13. Campbell RM, Ney AC, Gohh R, Robinson-Bostom L. Spiny hyperkeratotic projections on the face and extremities of a kidney transplant recipient. Arch Dermatol. 2006 Dec;142(12):1643-8
14. Tajirian A, Campbell RM, Robinson-Bostom L.  CME: Localized Argyria after exposure to aerosolized solder. Cutis. 2006 Nov;78(5):305-8.
15. Cruz A, Campbell RM, Perlis CS, Dufresne Jr. RG. Double purse-string closure for scalp and extremity wounds. Dermatol Surg. 2007 Mar;33(3):369-73
16. Jagdeo J, Campbell RM, Long T, Muglia J, Telang G, Robinson-Bostom L. Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia. J Am Acad Dermatol. 2007 Apr;56(4):690-3.
17. Campbell RM, Dufresne, Jr. RG.  Helical repair utilizing the subcutaneous island pedicle flap. Dermatol Surg. In Press.
18. Campbell RM, Harmon CB. Dermabrasion in our practice. J of Drugs Dermatol. In Press.
19. Campbell RM, Perlis CS, Mohsin M, Dufresne Jr RG. Characteristics of Mohs practices in the United States. Dermatol Surg. In Press

Book Chapters:

1. Campbell RM, Dufresne Jr RG. Wound Dehiscence and Necrosis. In: Gloster HM, ed. Complications in Cutaneous Surgery.  New York: Springer;2007. In Press.
2. Campbell RM, DiGiovanna JJ. Cutaneous Malignancies. In: Lowe N, Marks R. Topical and Systemic Retinoids: A Clinical Guide. Submitted.
3. Campbell RM, Monheit G. Chemical Peeling. In: Goldberg D. Facial Rejuvenation, A Total Approach. New York: Springer:2007. In Press. 

Abstracts and Presentations: 

1. 1. Landen J, Lang R, McMahon S, Adams A, Campbell R, Bonaccorsi, Archer D, Ansel J, C Armstrong and H Joshi.  Treatment of murine melanoma by, noscapine, a tubulin interacting agent. Poster. Proceedings of the AACR, March 2001.
2. Campbell RM. Newcastle Disease Virus oncolysate induces a significant and specific anti-melanoma effect in a preclinical murine model system. Oral Presentation. Society for Investigative Dermatology, Los Angeles, CA, May 2002.
3. Campbell RM, Stash J, Wang L, Robinson-Bostom L.  Rare Apocrine Fibroadenoma of Apocrine Skin. Oral Presentation. 62nd Annual Meeting of The American Academy of Dermatology.  Washington D.C.  February 2004.
4. Campbell RM, Dufresne R.  Meningiomas after medulloblastoma irradiation treatment in a patient with Basal Cell Nevus Syndrome. Poster. Summer Meeting, American Academy of Dermatology. New York City, NY. July 2004.
5. Capaldi L, Campbell RM, Kerr P, Gohh R, Robinson-Bostom L. Localized cutaneous posttransplant Epstein-Barr virus associated lymphoproliferative disorder.  Poster. ASDS-ACMMSCO Combined Meeting. San Diego, CA, October 2004.
6. Campbell RM, Barral D, Dufresne, Jr RG. Evaluation of Mohs margins by permanent histopathological evaluation. Oral Presentation. ASDS-ACMMSCO Combined Meeting, San Diego, CA, October 3, 2004.
7. Campbell RM, Lewis M., Robinson-Bostom L.  Localized Argyria After Exposure to Aerosolized Solder. Oral Presentation. 63rd Annual Meeting of The American Academy of Dermatology.  St. Louis, MI.  February 18, 2005.
8. Harwood M, Campbell RM, Reese V, Robinson-Bostom L.  Primary cutaneous Cryptococcus in an elderly pigeon breeder.  63rd Annual Meeting of The American Academy of Dermatology.  St. Louis, MI.  February 19, 2005.
9. Campbell RM, Regan LE MD, Dufresne RG, Muglia J, Robinson-Bostom L. Bednar Tumor: Treatment with Mohs micrographic surgery. Poster. Summer Meeting, American Academy of Dermatology. Chicago, IL. July 2005.
10. Campbell RM, Barrall D, Wilkel C, Robinson-Bostom L, Dufresne, Jr., RG. Recurrence rate of nonmelanoma skin cancer after Mohs excision and margin analysis by permanent histopathological evaluation. Poster. ASDS-ACMMSCO Combined Meeting. Atlanta, GA. October 2005.
11. Campbell RM, Dufresne, Jr. RG.  Helical repair utilizing the subcutaneous island pedicle flap. Poster and Oral Presentation. ASDS-ACMMSCO Combined Meeting. Atlanta, GA. October 28, 2005
12. Perlis CS, Campbell RM, Malik M, Dufresne Jr RG. Incidence of Medical Malpractice Suits Among Mohs Surgeons. Oral Presentation. ASDS-ACMMSCO Combined Meeting. Atlanta, GA. October 28, 2005
13. Jagdeo J, Campbell RM, Long T, Robinson-Bostom L. Sweet Syndrome panniculitis in a patient with acute promylocytic leukemia. Poster. The American Society of Dermatopathology 42nd Annual Meeting, Seattle WA. December 2005.
14. Campbell RM, Perlis CS, Mohsin M, Dufresne Jr RG. Characteristics of Mohs practices in the United States. Oral Presentation. ACMMSCO Annual Meeting. Scottsdale, AZ. April 27, 2006.
15. Campbell RM. Retinoid chemoprevention for skin cancer in organ transplant recipients. Dermatology Grand Rounds. Brown Medical School, Providence, RI. May 25, 2006.
16. Lewis K, Campbell RM, Jellinek N, Dufresne, Jr., RG. Dorsal hand repair using the subcutaneous island pedicle flap. Poster. ASDS Annual Palm Desert, CA. October 26-29, 2006.
17. Rupani RN, Campbell RM, Ney A, Gohh R, Robinson-Bostom L. Trichodysplasia of Immunosuppression. American Society of Dermatopathology Annual Conference, Chicago, IL. Oct 26th-29th, 2006.
18. Campbell RM, Elder J, Monheit G, Harmon C. “Confusing follicular proliferations” seen on Mohs slides: Dermatopathologic correlation and review of basaloid mimickers. Oral Presentation. Tromovitch Award Finalist. ACMMSCO Annual Meeting. Naples, FL. May 2007.

Research/Clinical Trials:

• 2007- Sub-investigator: A Single-Blind, Randomized, Single-Center Evaluation of Procedural and Post‑Procedural Pain Experienced With Injections of NADG with Lidocaine Injectable Gel as Compared to Captique® Injectable Gel in Subjects Undergoing Cutaneous Correction of Nasolabial Folds
• 2006- Sub-investigator: A Phase 3, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety of Repeat Administrations of Reloxin® in the Treatment of Glabellar Lines
• 2006- Sub-investigator: A Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles
• 2006- Sub-investigator: A Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Puretox neurotoxin Therapy in the Treatment of Glabellar Lines
• 2006- Sub-investigator: A Phase III Randomized, Blinded, Controlled, Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero, after mid-to-deep dermal implantation for Correction of Moderate to Severe Facial Wrinkles (such as nasolabial folds) over 24 Weeks
• 2006- Sub-investigator: A Double-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Aquamid® and Restylane® for the Aesthetic Treatment of Nasolabial Folds
• 2000-2002 “Melanoma immunotherapy with NDV oncolysate.” (Advisors: Cheryl Armstrong, M.D. and John Ansel, M.D.)  Emory University, Atlanta, GA.  Clinical trials, murine models, and basic science investigative studies.
• 2000-2002  “The effects of noscapine on hair growth.” (Advisors: Cheryl Armstrong, M.D. and John Ansel, M.D.)  Emory University, Atlanta, GA.  Murine models, and basic science investigative studies.  
• 2000-2002  “Substance P and angiogenesis.” (Advisors: Cheryl Armstrong, M.D. and John Ansel, M.D.)  Emory University, Atlanta, GA.  Developed tumor invasion assays and investigated chemoattractant properties of neuropeptides.